US Patent 10689643 Targeted transposition for use in epigenetic studies
Patent 10689643 was granted and assigned to ACTIVE MOTIF, INC. on June, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Mar, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10689643 Targeted transposition for use in epigenetic studies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10689643
Date of patent
June 23, 2020
Patent application number
14892911
Date Filed
May 22, 2014
Patent primary examiner
Find more entities like US Patent 10689643 Targeted transposition for use in epigenetic studies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.